While industry groups decried the Trump administration’s new drug pricing order, analysts say it lacked details and the teeth ...

As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are ...

To more effectively treat neurodegenerative conditions, we first need diagnostic tools that lend a more complete picture of ...

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...

Roche committed $50 billion in U.S. manufacturing funds, with which it will construct at least four new facilities.